Nate Young

Senior International Trade Specialist II

Overview

Nate Young is a Senior International Trade Specialist in Crowell & Moring’s Washington, D.C. office. With nearly 20 years of expertise in national security and foreign policy, Nate provides clients compliance advice on the U.S. Export Administration Regulations and International Traffic in Arms Regulations (ITAR). Nate assists in obtaining necessary export authorizations, conducting analyses on emerging and critical technologies, managing jurisdiction and classification requests, and handling ITAR registration actions. Nate actively monitors export control developments and is a regular contributor to Crowell’s international trade blog.

In his previous roles, Nate spent several years leading high-level projects for the U.S. Department of Defense and global aerospace firms. At the State Department, he was pivotal as a Senior Defense Trade Analyst and Outreach Coordinator at the Directorate of Defense Trade Controls and helped shape foreign military sales policy at the Bureau of Political-Military Affairs. He also served overseas at U.S. embassies in Russia, the Philippines, and Kazakhstan, where he wrote cables on political and economic developments. He began his career as a Presidential Management Fellow focusing on civil nuclear cooperation and nonproliferation policy.

Career & Education

    • Department of State
      • Senior Defense Trade Analyst and Outreach Coordinator, Directorate of Defense Trade Controls, 2016–2019
      • Foreign Affairs Officer, Bureau of Western Hemisphere Affairs, Office of Brazil and the Southern Cone, 2015–2016
      • Political Officer, U.S. Embassy Manila, Philippines, 2013–2015
      • Foreign Affairs Officer, Bureau of Political-Military Affairs, Office of Regional Security and Arms Transfers, 2010–2013
      • Foreign Affairs Officer, Bureau of European and Eurasian Affairs, Office of Policy and Regional Affairs, 2006–2010
      • Foreign Affairs Officer, U.S. Embassy Moscow, Russia, and U.S. Embassy Almaty, Kazakhstan, 2005–2008
    • Department of State
      • Senior Defense Trade Analyst and Outreach Coordinator, Directorate of Defense Trade Controls, 2016–2019
      • Foreign Affairs Officer, Bureau of Western Hemisphere Affairs, Office of Brazil and the Southern Cone, 2015–2016
      • Political Officer, U.S. Embassy Manila, Philippines, 2013–2015
      • Foreign Affairs Officer, Bureau of Political-Military Affairs, Office of Regional Security and Arms Transfers, 2010–2013
      • Foreign Affairs Officer, Bureau of European and Eurasian Affairs, Office of Policy and Regional Affairs, 2006–2010
      • Foreign Affairs Officer, U.S. Embassy Moscow, Russia, and U.S. Embassy Almaty, Kazakhstan, 2005–2008
    • Johns Hopkins University, M.A., School of Advanced International Studies (SAIS), international relations & economics
    • Northwestern University, B.A.,
      history and Slavic Studies
    • Johns Hopkins University, M.A., School of Advanced International Studies (SAIS), international relations & economics
    • Northwestern University, B.A.,
      history and Slavic Studies
    • Russian
    • Russian

Nate's Insights

Blog Post | 10.07.26

White House Issues Dual Section 232 Proclamations on Pharmaceuticals and Metals

On April 2, 2026, President Trump signed two presidential proclamations invoking Section 232 of the Trade Expansion Act of 1962 and Section 604 of the Trade Act of 1974 to impose significant new tariffs on imports of patented pharmaceuticals and pharmaceutical ingredients, and to restructure the existing tariff regime for aluminum, steel, and copper articles and their derivatives. The pharmaceutical proclamation targets patented drugs and active pharmaceutical ingredients (APIs), citing the Secretary of Commerce’s finding that approximately 53 percent of patented pharmaceutical products distributed domestically are produced outside the country, and only 15 percent of patented APIs by volume are domestically produced for the U.S. market. The metals proclamation amends three prior Section 232 actions — Proclamation 9704 of March 8, 2018 (aluminum), Proclamation 9705 of March 8, 2018 (steel), and Proclamation 10962 of July 30, 2025 (copper) — to restructure how tariffs are calculated and which derivative articles are covered.  The administration also issued two separate fact sheets for these actions....

Nate's Insights

Blog Post | 10.07.26

White House Issues Dual Section 232 Proclamations on Pharmaceuticals and Metals

On April 2, 2026, President Trump signed two presidential proclamations invoking Section 232 of the Trade Expansion Act of 1962 and Section 604 of the Trade Act of 1974 to impose significant new tariffs on imports of patented pharmaceuticals and pharmaceutical ingredients, and to restructure the existing tariff regime for aluminum, steel, and copper articles and their derivatives. The pharmaceutical proclamation targets patented drugs and active pharmaceutical ingredients (APIs), citing the Secretary of Commerce’s finding that approximately 53 percent of patented pharmaceutical products distributed domestically are produced outside the country, and only 15 percent of patented APIs by volume are domestically produced for the U.S. market. The metals proclamation amends three prior Section 232 actions — Proclamation 9704 of March 8, 2018 (aluminum), Proclamation 9705 of March 8, 2018 (steel), and Proclamation 10962 of July 30, 2025 (copper) — to restructure how tariffs are calculated and which derivative articles are covered.  The administration also issued two separate fact sheets for these actions....